Aiwu He (she/her) is a Oncologist in Washington, DC with over 18 years of experience. What is your opinion of Aiwu He? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Aiwu He has received over $308,643 which includes payments from the following companies:
$86,584.55 from Bayer HealthCare Pharmaceuticals Inc.
$54,132.37 from Exelixis Inc.
$50,345.89 from Eisai Inc.
$42,269.12 from E.R. Squibb & Sons, L.L.C.
$15,831.46 from Merck Sharp & Dohme Corporation
$12,326.95 from EMD Serono, Inc.
$10,823.21 from AstraZeneca UK Limited
$8,572.14 from ELI LILLY AND COMPANY
$7,871.58 from F. Hoffmann-La Roche AG
$7,245.73 from Regeneron Pharmaceuticals, Inc.
$4,539.50 from Sirtex Medical Inc
$4,003.91 from AstraZeneca Pharmaceuticals LP
$3,250.70 from Pfizer Inc.
$242.14 from Halozyme Inc
$142.51 from Varian Medical Systems, Inc.
$134.99 from AstraZeneca AB
$125.00 from Amgen Inc.
$105.82 from Genentech, Inc.
$67.46 from sanofi-aventis U.S. LLC
$28.45 from Incyte Corporation
Payments received by Aiwu He were from the following categories:
$157,557.57 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!